|
It was reported that on (b)(6) 2022, the patient underwent cataract surgery in the right eye (od) and the monofocal intraocular lens (iol) 17.5d was implanted.The iol was prepared with ophthalmic viscosurgical device (ovd) from another manufacturer.During surgery an hemorrhage due to canaloplasty occurred and a deep sclerotomy/suture canaloplasty suprachoroidal drainage was performed and an ologen implant (6 mm) was placed.The patient was hospitalized.On (b)(6) 2022, the patient was examined and presented an intraocular pressure (iop) of 2 mmhg (-22 mmhg from the baseline).The uncorrected distance visual acuity (ucdva) was hand movement.The patient presented with corneal edema, folds in descemet's and hyphema.The patient was also diagnosed with conjuctiva chemosis and stress folds.On (b)(6) 2022 the patient was examined and presented an iop of 5 mmhg (-19 mmhg from the baseline).The patient also presented with conjunctival hyperemia/injection and hyphema persisted.The patient was discharged.The hyphema was reported to be resolved without sequelae on (b)(6) 2022.Through follow-up, we learned that the patient is fully recovered.No further information was provided.
|
|
Section a2, a4 and a5: per regulation eu 2016/679 (general data protection regulation), patient identifiers were not collected or recorded and therefore are not available.Section d6b - explant date: not applicable, lens remains implanted.Section e1 - email address: unknown/not provided section e1 - telephone number: (b)(6) device evaluation: product testing could not be performed since the device was not returned for evaluation.Therefore, the reported issue could not be verified, and product quality deficiency could not be determined.Manufacturing records review: the manufacturing records for the product were reviewed.The product was manufactured and released according to specification.A search of complaints related to this production order (po) was performed.The search revealed that no additional complaints were received for this po.No escalation required.Conclusion: a product deficiency has not been identified; therefore, no additional corrective actions have been initiated.Attempts have been made to obtain the missing information.However, to date, no response has been received.All pertinent information available to johnson and johnson surgical vision, inc.Has been submitted.
|